Flavia Venetucci Gouveia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Flavia Venetucci Gouveia has a total of 198 co-authors. Here are the top co-authors by number of shared publications:
- Raquel Chacon Ruiz Martinez
Institute of Psychiatry, University of Sao Paulo School of Medicine
16 shared publications - Clement Hamani
Sunnybrook Research Institute
15 shared publications - Jürgen Germann
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
11 shared publications Peter Giacobbe
Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada; Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, Canada
10 shared publicationsNir Lipsman
Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada; Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, Canada; Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, Canada; Division of Neurosurgery, University of Toronto, Toronto, Canada
9 shared publicationsJürgen Germann
Division of Brain, Imaging and Behaviour, Krembil Research Institute, University Health Network and University of Toronto, Toronto, Canada; Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Canada
6 shared publications
Latest Publications
- Open Access
- 10 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (15) , eaeb5842
Regulation of autism-related self-injurious behavior by electrical stimulation of corticostriatal circuits in mice and humans
Dysfunction of corticostriatal circuitry is related to the emergence of self-injurious behavior (SIB) in autism spectrum disorder (ASD). Despite mounting interest in circuit-based interventions for severe, refractory SIB, the lack of causal evidence linking modulation of corticostriatal networks to changes in SIB has limited the advancement of effective, targeted therapies. In this study, we demonstrate that electrical stimulation of the nucleus accumbens (NAcc) mitigates SIB and induces structural changes along corticostriatal circuits in a mouse model relevant for ASD and children with severe SIB undergoing NAcc-targeted deep brain stimulation. In BTBR T + Itpr3 tf /J mice, NAcc stimulation selectively reduced injurious self-grooming—a behavioral metric of SIB—and led to morphological changes in corticostriatal networks. In children with severe SIB, electric stimulation at a locus of optimal therapeutic response within the NAcc engaged widespread sensorimotor, limbic, and striatal networks and induced longitudinal structural changes in fronto-limbic-striatal brain regions. These findings highlight the role of the fronto-limbic-striatal network in SIB regulation and support corticostriatal neuromodulation as a mechanistic therapy for these extreme behaviors.
- 10 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (15) , eaeb5842
Open AccessRegulation of autism-related self-injurious behavior by electrical stimulation of corticostriatal circuits in mice and humans
Dysfunction of corticostriatal circuitry is related to the emergence of self-injurious behavior (SIB) in autism spectrum disorder (ASD). Despite mounting interest in circuit-based interventions for severe, refractory SIB, the lack of causal evidence linking modulation of corticostriatal networks to changes in SIB has limited the advancement of effective, targeted therapies. In this study, we demonstrate that electrical stimulation of the nucleus accumbens (NAcc) mitigates SIB and induces structural changes along corticostriatal circuits in a mouse model relevant for ASD and children with severe SIB undergoing NAcc-targeted deep brain stimulation. In BTBR T + Itpr3 tf /J mice, NAcc stimulation selectively reduced injurious self-grooming—a behavioral metric of SIB—and led to morphological changes in corticostriatal networks. In children with severe SIB, electric stimulation at a locus of optimal therapeutic response within the NAcc engaged widespread sensorimotor, limbic, and striatal networks and induced longitudinal structural changes in fronto-limbic-striatal brain regions. These findings highlight the role of the fronto-limbic-striatal network in SIB regulation and support corticostriatal neuromodulation as a mechanistic therapy for these extreme behaviors.
- 26 July 2025
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 129, 1000-1013
Multimodal associations between brain morphology, immune-inflammatory markers, spatial transcriptomics, and behavioural symptoms in autism spectrum disorder
- 26 July 2025
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 129, 1000-1013
Multimodal associations between brain morphology, immune-inflammatory markers, spatial transcriptomics, and behavioural symptoms in autism spectrum disorder
- 24 July 2025
- Published by Elsevier in Experimental Neurology
- Vol. 393, 115394
Effects of centromedian thalamic deep brain stimulation on striatal glutamate and GABA in a rodent model of epilepsy
- 24 July 2025
- Published by Elsevier in Experimental Neurology
- Vol. 393, 115394
Effects of centromedian thalamic deep brain stimulation on striatal glutamate and GABA in a rodent model of epilepsy
- Open Access
- 14 April 2025
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 5
Longitudinal deformation-based morphometry pipeline to study neuroanatomical differences in structural MRI based on SyN unbiased templates
Morphometric measures in humans derived from magnetic resonance imaging (MRI) have provided important insights into brain differences and changes associated with development and disease in vivo. Deformation-based morphometry (DBM) is a registration-based technique that has been shown to be useful in detecting local volume differences and longitudinal brain changes while not requiring a priori segmentation or tissue classification. Typically, DBM measures are derived from registration to common template brain space (one-level DBM). Here, we present a two-level DBM technique: first, the Jacobian determinants are calculated for each individual input MRI at the subject level to capture longitudinal individual brain changes; then, in a second step, an unbiased common group space is created, and the Jacobians co-registered to enable the comparison of individual morphological changes across subjects or groups. This two-level DBM is particularly suitable for capturing longitudinal intra-individual changes in vivo, as calculating the Jacobians within-subject space leads to superior accuracy. Using artificially induced volume differences, we demonstrate that this two-level DBM pipeline is 4.5x more sensitive in detecting longitudinal within-subject volume changes compared to a typical one-level DBM approach. It also captures the magnitude of the induced volume change much more accurately. Using 150 subjects from the OASIS-2 dataset, we demonstrate that the two-level DBM is superior in capturing cortical volume changes associated with cognitive decline across patients with dementia and cognitively healthy individuals. This pipeline provides researchers with a powerful tool to study longitudinal brain changes with superior accuracy and sensitivity. It is publicly available and has already been used successfully, proving its utility.
- 14 April 2025
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 5
Open AccessLongitudinal deformation-based morphometry pipeline to study neuroanatomical differences in structural MRI based on SyN unbiased templates
Morphometric measures in humans derived from magnetic resonance imaging (MRI) have provided important insights into brain differences and changes associated with development and disease in vivo. Deformation-based morphometry (DBM) is a registration-based technique that has been shown to be useful in detecting local volume differences and longitudinal brain changes while not requiring a priori segmentation or tissue classification. Typically, DBM measures are derived from registration to common template brain space (one-level DBM). Here, we present a two-level DBM technique: first, the Jacobian determinants are calculated for each individual input MRI at the subject level to capture longitudinal individual brain changes; then, in a second step, an unbiased common group space is created, and the Jacobians co-registered to enable the comparison of individual morphological changes across subjects or groups. This two-level DBM is particularly suitable for capturing longitudinal intra-individual changes in vivo, as calculating the Jacobians within-subject space leads to superior accuracy. Using artificially induced volume differences, we demonstrate that this two-level DBM pipeline is 4.5x more sensitive in detecting longitudinal within-subject volume changes compared to a typical one-level DBM approach. It also captures the magnitude of the induced volume change much more accurately. Using 150 subjects from the OASIS-2 dataset, we demonstrate that the two-level DBM is superior in capturing cortical volume changes associated with cognitive decline across patients with dementia and cognitively healthy individuals. This pipeline provides researchers with a powerful tool to study longitudinal brain changes with superior accuracy and sensitivity. It is publicly available and has already been used successfully, proving its utility.
- 10 March 2025
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 172, 106101
Brain network alterations in fragile X syndrome
- 10 March 2025
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 172, 106101
Brain network alterations in fragile X syndrome
- Open Access
- 24 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1938
Molecular Pathways, Neural Circuits and Emerging Therapies for Self-Injurious Behaviour
Nonsuicidal self-injurious behaviour (SIB) is a debilitating manifestation of physical aggression commonly observed across neurodevelopmental, psychiatric, and genetic disorders. This behaviour arises from a multifactorial aetiology involving genetic predispositions, epigenetic modifications, neurotransmitter dysregulation, and environmental stressors. Dysregulation in dopaminergic, serotonergic, glutamatergic, and GABAergic systems has been implicated in the pathophysiology of SIB, alongside structural and functional abnormalities within fronto-limbic-striatal circuits. These disruptions impair key processes, such as emotional regulation, reward processing, and behavioural inhibition, contributing to the emergence and reinforcement of SIB. Advances in preclinical research using genetic, lesion-based, pharmacological, and environmental animal models have been instrumental in elucidating the molecular and neurocircuitry underpinnings of SIB. Emerging neuromodulation therapies targeting critical nodes within the fronto-limbic-striatal network, particularly deep brain stimulation, have shown promise in treating severe, refractory SIB and improving quality of life. This review integrates current evidence from clinical studies, molecular research, and preclinical models to provide a comprehensive overview of the pathophysiology of SIB and therapeutic approaches. By focusing on the molecular mechanisms and neural circuits underlying SIB, we highlight the translational potential of emerging pharmacological and neuromodulatory therapies. A deeper understanding of these pathways will pave the way for precision-based interventions, bridging the gap between molecular research and clinical applications in SIB and related conditions.
- 24 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1938
Open AccessMolecular Pathways, Neural Circuits and Emerging Therapies for Self-Injurious Behaviour
Nonsuicidal self-injurious behaviour (SIB) is a debilitating manifestation of physical aggression commonly observed across neurodevelopmental, psychiatric, and genetic disorders. This behaviour arises from a multifactorial aetiology involving genetic predispositions, epigenetic modifications, neurotransmitter dysregulation, and environmental stressors. Dysregulation in dopaminergic, serotonergic, glutamatergic, and GABAergic systems has been implicated in the pathophysiology of SIB, alongside structural and functional abnormalities within fronto-limbic-striatal circuits. These disruptions impair key processes, such as emotional regulation, reward processing, and behavioural inhibition, contributing to the emergence and reinforcement of SIB. Advances in preclinical research using genetic, lesion-based, pharmacological, and environmental animal models have been instrumental in elucidating the molecular and neurocircuitry underpinnings of SIB. Emerging neuromodulation therapies targeting critical nodes within the fronto-limbic-striatal network, particularly deep brain stimulation, have shown promise in treating severe, refractory SIB and improving quality of life. This review integrates current evidence from clinical studies, molecular research, and preclinical models to provide a comprehensive overview of the pathophysiology of SIB and therapeutic approaches. By focusing on the molecular mechanisms and neural circuits underlying SIB, we highlight the translational potential of emerging pharmacological and neuromodulatory therapies. A deeper understanding of these pathways will pave the way for precision-based interventions, bridging the gap between molecular research and clinical applications in SIB and related conditions.
- 5 December 2024
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 28 (3) , 401-413
Systematic Review of Experimental Deep Brain Stimulation in Rodent Models of Epilepsy
- 5 December 2024
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 28 (3) , 401-413
Systematic Review of Experimental Deep Brain Stimulation in Rodent Models of Epilepsy
- Open Access
- 11 April 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-25
Systematic review of rodent studies of deep brain stimulation for the treatment of neurological, developmental and neuropsychiatric disorders
Deep brain stimulation (DBS) modulates local and widespread connectivity in dysfunctional networks. Positive results are observed in several patient populations; however, the precise mechanisms underlying treatment remain unknown. Translational DBS studies aim to answer these questions and provide knowledge for advancing the field. Here, we systematically review the literature on DBS studies involving models of neurological, developmental and neuropsychiatric disorders to provide a synthesis of the current scientific landscape surrounding this topic. A systematic analysis of the literature was performed following PRISMA guidelines. 407 original articles were included. Data extraction focused on study characteristics, including stimulation protocol, behavioural outcomes, and mechanisms of action. The number of articles published increased over the years, including 16 rat models and 13 mouse models of transgenic or healthy animals exposed to external factors to induce symptoms. Most studies targeted telencephalic structures with varying stimulation settings. Positive behavioural outcomes were reported in 85.8% of the included studies. In models of psychiatric and neurodevelopmental disorders, DBS-induced effects were associated with changes in monoamines and neuronal activity along the mesocorticolimbic circuit. For movement disorders, DBS improves symptoms via modulation of the striatal dopaminergic system. In dementia and epilepsy models, changes to cellular and molecular aspects of the hippocampus were shown to underlie symptom improvement. Despite limitations in translating findings from preclinical to clinical settings, rodent studies have contributed substantially to our current knowledge of the pathophysiology of disease and DBS mechanisms. Direct inhibition/excitation of neural activity, whereby DBS modulates pathological oscillatory activity within brain networks, is among the major theories of its mechanism. However, there remain fundamental questions on mechanisms, optimal targets and parameters that need to be better understood to improve this therapy and provide more individualized treatment according to the patient’s predominant symptoms.
- 11 April 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-25
Open AccessSystematic review of rodent studies of deep brain stimulation for the treatment of neurological, developmental and neuropsychiatric disorders
Deep brain stimulation (DBS) modulates local and widespread connectivity in dysfunctional networks. Positive results are observed in several patient populations; however, the precise mechanisms underlying treatment remain unknown. Translational DBS studies aim to answer these questions and provide knowledge for advancing the field. Here, we systematically review the literature on DBS studies involving models of neurological, developmental and neuropsychiatric disorders to provide a synthesis of the current scientific landscape surrounding this topic. A systematic analysis of the literature was performed following PRISMA guidelines. 407 original articles were included. Data extraction focused on study characteristics, including stimulation protocol, behavioural outcomes, and mechanisms of action. The number of articles published increased over the years, including 16 rat models and 13 mouse models of transgenic or healthy animals exposed to external factors to induce symptoms. Most studies targeted telencephalic structures with varying stimulation settings. Positive behavioural outcomes were reported in 85.8% of the included studies. In models of psychiatric and neurodevelopmental disorders, DBS-induced effects were associated with changes in monoamines and neuronal activity along the mesocorticolimbic circuit. For movement disorders, DBS improves symptoms via modulation of the striatal dopaminergic system. In dementia and epilepsy models, changes to cellular and molecular aspects of the hippocampus were shown to underlie symptom improvement. Despite limitations in translating findings from preclinical to clinical settings, rodent studies have contributed substantially to our current knowledge of the pathophysiology of disease and DBS mechanisms. Direct inhibition/excitation of neural activity, whereby DBS modulates pathological oscillatory activity within brain networks, is among the major theories of its mechanism. However, there remain fundamental questions on mechanisms, optimal targets and parameters that need to be better understood to improve this therapy and provide more individualized treatment according to the patient’s predominant symptoms.
- Open Access
- 27 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10693
Unravelling the Role of Habenula Subnuclei on Avoidance Response: Focus on Activation and Neuroinflammation
Understanding the mechanisms responsible for anxiety disorders is a major challenge. Avoidance behavior is an essential feature of anxiety disorders. The two-way avoidance test is a preclinical model with two distinct subpopulations—the good and poor performers—based on the number of avoidance responses presented during testing. It is believed that the habenula subnuclei could be important for the elaboration of avoidance response with a distinct pattern of activation and neuroinflammation. The present study aimed to shed light on the habenula subnuclei signature in avoidance behavior, evaluating the pattern of neuronal activation using FOS expression and astrocyte density using GFAP immunoreactivity, and comparing control, good and poor performers. Our results showed that good performers had a decrease in FOS immunoreactivity (IR) in the superior part of the medial division of habenula (MHbS) and an increase in the marginal part of the lateral subdivision of lateral habenula (LHbLMg). Poor performers showed an increase in FOS in the basal part of the lateral subdivision of lateral habenula (LHbLB). Considering the astroglial immunoreactivity, the poor performers showed an increase in GFAP-IR in the inferior portion of the medial complex (MHbl), while the good performers showed a decrease in the oval part of the lateral part of the lateral complex (LHbLO) in comparison with the other groups. Taken together, our data suggest that specific subdivisions of the MHb and LHb have different activation patterns and astroglial immunoreactivity in good and poor performers. This study could contribute to understanding the neurobiological mechanisms responsible for anxiety disorders.
- 27 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10693
Open AccessUnravelling the Role of Habenula Subnuclei on Avoidance Response: Focus on Activation and Neuroinflammation
Understanding the mechanisms responsible for anxiety disorders is a major challenge. Avoidance behavior is an essential feature of anxiety disorders. The two-way avoidance test is a preclinical model with two distinct subpopulations—the good and poor performers—based on the number of avoidance responses presented during testing. It is believed that the habenula subnuclei could be important for the elaboration of avoidance response with a distinct pattern of activation and neuroinflammation. The present study aimed to shed light on the habenula subnuclei signature in avoidance behavior, evaluating the pattern of neuronal activation using FOS expression and astrocyte density using GFAP immunoreactivity, and comparing control, good and poor performers. Our results showed that good performers had a decrease in FOS immunoreactivity (IR) in the superior part of the medial division of habenula (MHbS) and an increase in the marginal part of the lateral subdivision of lateral habenula (LHbLMg). Poor performers showed an increase in FOS in the basal part of the lateral subdivision of lateral habenula (LHbLB). Considering the astroglial immunoreactivity, the poor performers showed an increase in GFAP-IR in the inferior portion of the medial complex (MHbl), while the good performers showed a decrease in the oval part of the lateral part of the lateral complex (LHbLO) in comparison with the other groups. Taken together, our data suggest that specific subdivisions of the MHb and LHb have different activation patterns and astroglial immunoreactivity in good and poor performers. This study could contribute to understanding the neurobiological mechanisms responsible for anxiety disorders.